Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 168

    1.

    A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration.

    Armbrecht AM, Aspinall PA, Dhillon B.

    Br J Ophthalmol. 2004 Oct;88(10):1270-3.PMID: 15377549 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

    Lüke M, Ziemssen F, Völker M, Altpeter E, Beutel J, Besch D, Bartz-Schmidt KU, Gelisken F.

    Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):745-54. Epub 2009 Feb 12.PMID: 19214552 [PubMed - indexed for MEDLINE]Related articles

    3.

    Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

    Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

    Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

    4.

    Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.

    Sharp DM, Lai S, Markey CM.

    Clin Experiment Ophthalmol. 2007 Jan-Feb;35(1):24-31.PMID: 17300567 [PubMed - indexed for MEDLINE]Related articles

    5.

    Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.

    Slakter JS, Bochow TW, D'Amico DJ, Marks B, Jerdan J, Sullivan EK, Robertson SM, Slakter JS, Sullins G, Zilliox P; Anecortave Acetate Clinical Study Group.

    Ophthalmology. 2006 Jan;113(1):3-13. Epub 2005 Dec 20.PMID: 16368146 [PubMed - indexed for MEDLINE]Related articles

    7.

    Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles

    8.

    Photodynamic therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.

    Shyong MP, Lee FL, Chen SJ, Tung TH, Tsai DC, Hsu WM.

    J Chin Med Assoc. 2005 Sep;68(9):419-24.PMID: 16187598 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Assessment of the quality of life in patients with age-related macular degeneration 1 year after photodynamic therapy]

    Kyo T, Yuzawa M, Tochigi K, Yamaguchi T, Shimozuma K, Fukuhara S, Matsumoto Y.

    Nippon Ganka Gakkai Zasshi. 2007 Apr;111(4):315-21. Japanese. PMID: 17461036 [PubMed - indexed for MEDLINE]Related articles

    10.

    Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation).

    Ziemssen F, Lüke M, Bartz-Schmidt KU, Gelisken F.

    Graefes Arch Clin Exp Ophthalmol. 2008 May;246(5):653-9. Epub 2007 Dec 11.PMID: 18071731 [PubMed - indexed for MEDLINE]Related articles

    11.

    Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

    Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

    Arch Ophthalmol. 2005 Apr;123(4):448-57.PMID: 15824216 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Photodynamic therapy in age-related macular degeneration: one-year results]

    Ohira-Tochigi K, Yokoyama E, Matsumoto Y, Kyo T, Yuzawa M.

    Nippon Ganka Gakkai Zasshi. 2008 Oct;112(10):855-62. Japanese. PMID: 18949910 [PubMed - indexed for MEDLINE]Related articles

    13.

    Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration--a report of 1 year results.

    Lüke M, Ziemssen F, Bartz-Schmidt KU, Gelisken F.

    Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1831-6. Epub 2007 Mar 9.PMID: 17347809 [PubMed - indexed for MEDLINE]Related articles

    14.

    Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

    Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1085-95.PMID: 17219106 [PubMed - indexed for MEDLINE]Related articles

    15.

    12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.

    Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.

    Retina. 2008 Feb;28(2):289-97.PMID: 18301052 [PubMed - indexed for MEDLINE]Related articles

    16.

    Photodynamic therapy for age-related macular degeneration treatment: epidemiological and clinical analysis of a long-term study.

    Mataix J, Desco MC, Palacios E, Garcia-Pous M, Navea A.

    Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):277-84.PMID: 19485292 [PubMed - indexed for MEDLINE]Related articles

    17.

    Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

    Nicolò M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G.

    Retina. 2006 Jan;26(1):58-64.PMID: 16395140 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

    Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

    Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.PMID: 18462575 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.

    Schadlu R, Kymes SM, Apte RS.

    Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1667-72. Epub 2007 Jun 22.PMID: 17583819 [PubMed - indexed for MEDLINE]Related articles

    20.

    Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2005 Feb;112(2):301-4.PMID: 15691567 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data